Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Connect Biopharma Holdings ( (CNTB) ) just unveiled an update.
On July 18, 2025, Connect Biopharma Holdings announced its decision to terminate the Deposit Agreement with Deutsche Bank Trust Company Americas, which governs its American Depositary Shares (ADSs) on the Nasdaq Global Market. The termination is set to occur around September 2, 2025, after which the company’s ADRs will be cancelled and exchanged for Ordinary Shares at a one-for-one ratio. Connect Biopharma plans to list its Ordinary Shares directly on Nasdaq, replacing its ADSs under the existing symbol ‘CNTB’. This move is expected to streamline the company’s market presence and potentially impact its operations and stakeholder interests.
The most recent analyst rating on (CNTB) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Connect Biopharma Holdings stock, see the CNTB Stock Forecast page.
Spark’s Take on CNTB Stock
According to Spark, TipRanks’ AI Analyst, CNTB is a Neutral.
Connect Biopharma Holdings’ overall score reflects the challenges of unprofitability and negative cash flow despite recent revenue growth and a strong balance sheet. Technical indicators suggest a bearish trend, while the valuation highlights the risks typical of early-stage biotech firms. However, the positive corporate event regarding FDA support for Phase 2 trials offers a promising growth opportunity in the pipeline, improving the outlook.
To see Spark’s full report on CNTB stock, click here.
More about Connect Biopharma Holdings
Connect Biopharma Holdings Limited operates in the biopharmaceutical industry, focusing on the development of therapies for the treatment of inflammatory diseases. The company is engaged in drug development and commercialization, which involves a high degree of risk.
Average Trading Volume: 115,814
Technical Sentiment Signal: Buy
Current Market Cap: $95.21M
For a thorough assessment of CNTB stock, go to TipRanks’ Stock Analysis page.